WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Stock Ownership - Who owns Ascendis Pharma A?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ascendis Pharma A insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott Thomas SmithEVP Chief Financial Officer2026-06-02100$219.00
$21.90kBuy
Jean Jacques BienaimeDirector2026-05-29200$223.76
$44.75kBuy
Jean Jacques BienaimeDirector2026-05-29200$222.30
$44.46kBuy
Jean Jacques BienaimeDirector2026-05-29100$223.50
$22.35kBuy
Scott Thomas SmithEVP Chief Financial Officer2026-05-29250$223.32
$55.83kBuy
Jean Jacques BienaimeDirector2026-05-26200$239.37
$47.87kBuy
Jean Jacques BienaimeDirector2026-05-26200$236.24
$47.25kBuy
Flemming Steen JensenEVP Product Supply and Quality2026-05-1119,460$238.49
$4.64MSell

1 of 1

ASND insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ASND insiders and whales buy or sell their stock.

ASND Shareholders

What type of owners hold Ascendis Pharma A stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP16.55%10,281,496$2.37BInstitution
T Rowe Price Investment Management Inc9.92%6,162,042$1.42BInstitution
Avoro Capital Advisors LLC8.15%5,062,500$1.17BInstitution
Westfield Capital Management Co LP7.75%4,813,440$1.11BInstitution
Fmr LLC6.24%3,876,601$894.84MInstitution
Artisan Partners Limited Partnership5.20%3,230,188$745.62MInstitution
Franklin Resources Inc3.30%2,051,948$473.65MInstitution
Capital International Investors3.15%1,958,843$452.16MInstitution
Massachusetts Financial Services Co3.00%1,860,669$429.50MInstitution
Wellington Management Group LLP2.83%1,757,633$405.71MInstitution

1 of 3

ASND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASND99.19%0.81%Net SellingNet Selling
JAZZ29.89%70.11%Net SellingNet Selling
EXEL94.86%5.14%Net SellingNet Selling
BBIO64.71%35.29%Net SellingNet Selling
AXSM62.19%37.81%Net SellingNet Selling
View Top Biotech Stocks

Ascendis Pharma A Stock Ownership FAQ

Who owns Ascendis Pharma A?

Ascendis Pharma A (NASDAQ: ASND) is owned by 100.87% institutional shareholders, 0.83% Ascendis Pharma A insiders, and 0.00% retail investors. Jan Moller Mikkelsen is the largest individual Ascendis Pharma A shareholder, owning 453,403.00 shares representing 0.73% of the company. Jan Moller Mikkelsen's Ascendis Pharma A shares are currently valued at $104.66M.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.